Charles Garner
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Charles Garner
Charles Garner is recorded as CFO at Rein Therapeutics, Inc. (RNTX). Rein Therapeutics, Inc. reported in an 8-K filed March 29, 2024 that Charles Garner was appointed principal financial officer and principal accounting officer, effective March 25, 2024.
“To replace Ms. Drexler, the Board of Directors of the Company appointed Charles Garner to serve as the Company's principal financial officer and principal accounting officer, effective as of March 25, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-03-25–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rein Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Windsor CEO, COO, Board Member
- Brian Windsor, Ph.D. CEO, COO, Board Member
- Josef H. von Rickenbach Chairman, Board Member
- Donald V. Dougherty CFO
- Timothy M. Cunningham CFO
- Manuel Aivado Chief Accounting Officer
- Alan A. Musso Board Member
- Manuel C. Alves-Aivado, M.D., Ph.D. Board Member
- Reinhard Ambros, Ph.D. Board Member
- Reinhard J. Ambros Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.